Can weight-loss medicine save the aviation trade (some cash)?

Keep knowledgeable with free updates

Merely signal as much as the Prescription drugs sector myFT Digest — delivered on to your inbox.

Alphaville has been receiving a LOT of fairness analysis associated to the influence of weight-loss medicine resembling Ozempic* and Wegovy (mainFT has an incredible overview right here).

Because the efficiency of those therapies turns into evident, many analysts are asking a elementary query about their sectors: “What occur to the businesses I cowl if urge for food suppression turns into simply obtainable to a part of the inhabitants?”

Many analysts have taken a tilt currently, with hypotheses together with:

— gyms will promote extra memberships
— gyms will promote fewer memberships
— outlets will promote extra garments
— outlets will promote much less and fewer garments
— folks will purchase extra beauty therapies
— folks will purchase fewer beauty therapies
— folks will spend extra on journey
— folks will spend much less on journey

and so on.

Amongst all of this, there was one apparent and burning query, which Citi has lastly answered. From our inbox at the moment:

CITI’S TAKE
It’s doable that elevated use of Ozempic, Wegovy and associated weight reduction/diabetes therapies may materially contribute to weight reduction efforts of its customers in the US. Nonetheless, digging by a few of our latest work on A320 flight capabilities, the potential payload profit from transporting lighter passengers is negligible, particularly on shorter-distance flights. Use of those therapies would appear to have to be much more widespread to have any significant influence on A320 mission capabilities. Citi maintains Purchase rankings on Delta, Copa, United, Air France/KLM, Volaris and Azul, amongst others.

OK, it’s not a very absurd notion. Take-off weight is a vital difficulty for airways, which have devoted plenty of consideration to creating their plane lighter. However this seems actually marginal. Right here’s how Citi crunched the numbers:

With an estimated 9M customers of Ozempic and Wegovy within the US or 3% of the inhabitants, Citi examined a state of affairs during which considerably elevated use of those medicine would make solely a marginal distinction in plane payloads. The fundamental assumptions and concerns of this train are as follows:

— There are ̴160 passengers on board the typical home flight.

— The common weight per passenger — from infants to the aged — is 150 lbs.

— The full human payload weight of the typical flight is 24,000lbs (160 passengers x 150lbs every =24,000).

— Air vacationers are in all probability wealthier than the typical resident — which means they’re additionally extra prone to afford these medicine.

— 9% of home passengers are Ozempic and/or Wegovy customers or triple the present fee of penetration.

— 9% of passengers per flight would imply a median of 14.4 passengers per flight (9% of 160 pax) use these weight reduction medicine (let’s spherical that all the way down to 14 passengers).

— The common weight of all different passengers stays unchanged.

— These 14 passengers lose 10lbs every. That may drop the entire human payload weight per flight from 24,000 lbs to 23,860 lbs (146 passengers x 150lbs every + 14 passengers x 140 lbs every = 21,900 + 1,960 = 23,860). This is able to equate to a human payload discount of simply 0.6%.

— There isn’t any discount in demand for buy-on-board meals merchandise or associated companies resembling airport meals courts as a result of these customers eat much less.

— There proceed to be no critical long-term uncomfortable side effects of both drug.

After all, the 140lb drop in payload roughly equates to 1 grownup, however this doesn’t imply that there would now be one additional obtainable seat on the aircraft. Beginning on the age of two years, every passenger requires their very own seat.

They add, regardless of having undertaken the above train:

It’s also essential to note that extra detailed evaluation on gasoline consumption or seat mile value enhancements attributable to passenger weight discount aren’t simple. These estimates range primarily based on route situations resembling climb and descent profile, cruise altitude, in-flight temperature, flight distance, amongst others, whereas the calculation of these results is dependent upon knowledge which can be typically not obtainable within the public area.

So there you go.

*Replace: A flack for Novo Nordisk has requested us to make clear that Ozempic is a diabetes therapy, and to remind readers that its widespread use as a weight-loss drug is “off-label”. We apologise to anybody who started medicating themselves primarily based on this text.